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Abstract  Article Information 
Highly Active Antiretroviral Therapy (HAART) has resulted reduction of mortality and 
improved quality of life of peoples living with HIV/AIDS. Maximum benefits can only be 
achieved through maximum adherence. We designed this study to assess rate and predictors 
of adherence to antiretroviral therapy at Tepi health center. A facility based cross-sectional 
study was conducted through patient’s self report using structured pre-tested questionnaires 
and medical record of the clients in a total of 341 samples using systematic random sampling 
technique. The data were collected from January1, 2012 to February15, 2012 in Tepi health 
centre. The data was analyzed using SPSS version 16. Multiple logistic regression model was 
constructed to determine predictors of adherence. Self-reported dose adherence in the study 
area was 78.6% and that of combined indicator was 43.4%. Positive predictors of adherence 
includes alcohol drinking (AOR=4.36, 95% CI =2.03, 9.35), and a belief of ART cures HIV 
(AOR = 1.95, 95% CI = 1.21, 3.13) while long-duration on HAART (≥49 months) (AOR=0.29, 
95%CI=0.11, 0.75) was negative predictor. The adherence rate in this study was much less 
than studies in many parts of Ethiopia. Interventions should target on reduction of alcohol use 
and on imparting appropriate knowledge of HAART that will address false beliefs of “ART 
cures HIV”.    
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INTRODUCTION 
Highly active antiretroviral therapy (HAART) is a 
breakthrough and celebrated in the reduction of mortality 
and in the improvement of quality of life of PLWHA. Since 
the introduction of HAART in 1995, important reduction in 
HIV progression to both AIDS and death is observed 
(Cooke, Lee et al. 2014; Dewing, Mathews et al., 2014). 
Antiretroviral therapy (ART) is designed to suppress viral 
replication and thus reduce the likelihood of development 
of drug resistant viral strain and also prevents further viral 
destruction of the cellular immune system (Edison Hughes 
et al., 2014).  
 
Adherence to HAART is one of potentially alterable 
factors determining outcomes for patients with HIV (Lee 
Rand et al., 2014). However non-adherence to HAART is 
common in all groups of treated individuals (Tiyou 
Belachew et al., 2010; Maqutu Zewotir et al., 2011; 
Mirkuzie Hinderaker et al., 2011; Kebede and Wabe, 
2012; Mengistu and Chere, 2012; Biressaw Abegaz et al., 
2013; Arage Tessema et al., 2014; Mulu Liebert et al., 
2014).To achieve goal of HAART maximal and durable 
viral suppression and successful HIV therapy requires 
adherence of ≥ 95% (Hassan, Nabwera et al., 2014). 
Failure rates increase sharply as adherence decrease 
(Edison Hughes et al., 2014). 
 
Literature survey shows that, there are no studies 
conducted at health center level in Ethiopia where as a 
large segment of population is treated at health center. 
This study was therefore designed to determine the 
adherence rate and determinates of adherence to HAART 
among clients on ART in Tepi health center. 
 
MATERIALS AND METHODS 
Study Area and Design 
Data was collected from January 1, 2012 to February 
15, 2012 in Tepi health centre. Tepi health centre is 
located in Tepi town Sheka zone, SNNPR. Tepi town is 
565 kilometers away from Addis Ababa (capital of 
Ethiopia) ART had been commenced in Tepi health center 
in 2005.  
 
A facility based cross-sectional observational study 
was conducted through patient’s self report using 
structured questionnaires and medical record of the 
clients. The study population was all PLWHA on HAART 
for at least three months and following their treatment 
follow-up from January 1, 2012 to February 15, 2012. 
Clients on treatment for less than 3 months, under the age 
of 18 years and with severe acute illness were excluded 
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Sample Size and Sampling Technique 
A sample size was calculated using a similar study 
from Jimma University Specialized Hospital which has a 
combined self reported adherence rate of 72.4 9. Single 
population proportion formula with 95% confidence 
interval was used and the sample size was calculated to 
be 341. The sampled population was selected using 
simple random sampling technique.  
 
Data Collection Tool 
Data were collected on structured pre-tested 
questionnaire by interviewing clients and transferring 
clinical information such as CD4 cells, WHO Stage, 
duration on treatment and regimen from medical records. 
The questionnaire was adapted from studies from other 
Ethiopian studies (Tadios and Davey, 2006; Amberbir 
Woldemichael et al., 2008; Tiyou and Belachew et al., 
2010; Emiru and Wakgari, 2014). The questionnaire was 
developed in English and translated to Amharic. The 
clients were interviewed for variables. Data collection was 
conducted at ART clinic of Tepi health center by trained 
health professionals. The questionnaire was pre-tested on 
5% of study population and the data was not included in 
actual study.  
 
Adherence status is a dependent variable while 
independent variables includes Socio-demographic and 
economic characteristics (age, sex, ethnic group, 
residence, distance from service facility, religion, 
education, employment, marital status, monthly income 
and having cell/public phone), clinical characteristics of 
the disease (WHO staging, CD4 count), duration on 
treatment and regimen type. Disclosure status, 
psychosocial support and substance and alcohol use, 
adherence to treatment information, attitudinal factors 
contributing for non-adherence was also assessed. 
 
Data Quality and Analysis    
The data was collected using structured pre-tested 
questionnaire under control of the investigator through 
trained data collectors five clinical nurses and a senior 
nurse supervising them. The completeness and logical 
consistency of the data was checked and corrected at the 
spot during data collection.  
 
The collected data was edited, cleaned, coded and 
entered into Epi Info version 7 and then exported to SPSS 
version 16 for analysis. Finally data was summarized 
using descriptive statistics to assess basic client 
characteristics such as socio-demographic status and for 
the calculation of adherence rate. Predictors of adherence 
were determined using logistic regression. In bivariate 
analysis each independent variable was tested for the 
presence of association with the dependent variable. After 
bivariate analysis, final multivariate analysis was 
conducted.  
 
Self reported dose adherence to all antiretroviral 
agents could be summarized as the ratio of the average 
daily number of antiretroviral medications adhered to total 
number of antiretroviral medication prescribed (Tadios 
and Davey, 2006). These can be written in the following 
way: 
   
Adherence rate =                
 =(Number of doses prescribed-Number of doses missed) X 100 
Number of doses prescribed 
 
Ethical Consideration  
The study proposal was approved by institutional 
ethical review committee of Hawassa University and 
Addis Continental Institute of Public Health. Permission 
obtained from Sheka zone health department and Tepi 
town administration health office to conduct the study. 
Informed consent obtained from every respondent before 




Socio-demographic and Economic Characteristics 
A total of 341 study subjects were included in this 
study. The majority of the study participants were between 
the age group of 25-34 about 146 (42.8%) with mean (SD) 
of 35±9.6 and a range of 50. The rural population 
comprise 211 (61.9%) of the study participants. 175 
(51.3%) of the study participants have less than 1km 
distance from the health service facility. 209 (61.3%) of 
the study subjects were Orthodox Christian, while the 
14.7% Protestant and 24.0% Muslim. The whole socio-
demographic data of the study participants were 
summarized in table 1. 
 
Table 1: Socio-demographic & Economic characteristics 
of ART clients in Tepi HC, (n=341), Tepi 2012 
 
Variable Number Percent (%) 
Age   
   18-24 28 8.2 
   25-34 146 42.8 
   35-44 111 32.6 
   45+ 56 16.4 
Sex   
   Male 151 44.3 
   Female 190 55.7 
Residence   
    Urban 130 38.1 
    Rural 211 61.9 
Distance    
    <1Km 175 51.3 
    1-5Km 44 12.9 
    6-10Km 62 18.2 
    >10Km 60 17.6 
Educational level   
   No formal education 96 28.2 
   1-8 189 55.4 
   9-12 37 10.9 
   12+ 19 5.6 
Marital status   
   Single 42 12.3 
   Married  161 47.2 
   Divorced 86 25.2 
   Widowed 47 13.8 
   Cohabitating 5 1.5 
Employment     
   Employed 42 12.3 
   Unemployed  299 87.7 
Monthly Income   
   No source  35 10.3 
   <400 189 55.4 
   401 – 1000 81 23.8 
   1001 – 2000 30 8.8 
    >2000 6 1.8 
  Cell/public phone   
    Yes 182 53.4 
    No 159 46.6 
 
















Forgeting Being away from 
home





Reasons for dose non-adherence
216(63.3%) of the study participants believe taking 
ART reminds their HIV sero-status and 53(15.5%) believe 
that taking ART continuously could harm them. About half 
of the study participants 51.3% believe “ART cures 
HIV/AIDS”.  
 
Majority 269(78.9%) of the study subjects were in 
WHO stage III during initiation while 2(0.6%) were on 
asymptomatic stage (stage I). Baseline CD4 cell count 
<200cells/m
3
 contributes for 137(40.2%) and a CD4 range 
350–500 cells/m
3
 about 16(4.7%), nearly 30% of the 
clients have no recorded baseline CD4 count. More than 
half 188(55.1%) of clients has no recorded recent CD4 
count either because of failure to record or were not totally 
measured. 60(17.6%) clients have a range of CD4 cell 
200-350 cells/m
3
. 91(26.7%) have been on HAART for 3-
12 months, while 45(13.2%) for more than 49 months. 
Predominantly, 113(33.1%) of study participants were on 
regimen containing D4T+3TC+NVP, whereas 19(5.6%) 
were on TDF+ 3TC+NVP. 
 
Rate of Adherence and Reasons for Non-adherence 
Missed doses were assessed for “the day before”, 
“past three days” (three days recall) and “past seven 
days” (seven days recall). 11.7% of clients missed at least 
a single dose of drug the day before, 17.9% missed at 
least a dose in three days recall, while 22.3 missed at 
least a dose in seven days recall as shown in table 2.  
 
Table3 summarizes that 268(78.6%) of the participants 
were dose adherent, while 207(60.7%) were 
time/schedule adherent and 221(70.8%) were food 
adherent (follow the food restriction). The overall 
adherence (dose, time and food) calculated by using 
participants who were adherent in all (dose, time/schedule 
and food) was 148(43.4%).  
 
Forgetting and being away from home are the major 
reasons for dose non-adherence as indicated in figure 1. 
Table 2: No. of Clients missed at least a tablet by self-
report in Tepi HC (n = 341) 
 
No. of days Number Percent (%) 
The day before   
     Yes 40 11.7 
     No 301 88.3 
Past three days   
     Yes 61 17.9 
     No 280 82.1 
Past seven days   
    Yes 76 22.3 
    No 265 77.7 
 
Table 3: Self reported (dose, time, food and overall) 
adherence among ART clients in Tepi health 
center (n=341), Tepi 2012. 
 
Variables Number Percent (%) 
Self reported 7-day  
recall dose adherence 
   Adherent 268 78.6 
   Non-Adherent 73 21.4 
Time(schedule) adherence   
   Adherent 207 60.7 
   Non-Adherent 134 39.3 
Is there food restriction in 
your regimen? 
   No 312 91.5 
   Yes 29 8.5 
Food adherence 
(following restrictions) 
   Adherent 221 70.8 
   Non-Adherent 91 29.2 
Over all adherence 
(dose, time and food ) 
   Adherent 148 43.4 
   Non-Adherent 193 56.6 
 
 
Figure 1: Reasons for dose non-adherence 
 
Predictors of Adherence 
In bivarate analysis each independent variables were 
tested with the overall adherence for association. 
Variables such as family support, alcohol use and a belief 
that “ART cures HIV/AIDS” were found to be significantly 
associated with the adherence. Family support was likely 
to increase adherence by odds of 1.8 times (COR=1.8, 
95% CI=1.07, 3.01). Not using alcohol was likely to 
increase adherence by odds of 3.7 times (COR=3.69, 
95% CI=1.83, 7.41). Not having belief of “ART cures 
HIV/AIDS” was likely to increase adherence by odds of 
1.7 times (COR=1.69, CI=1.10, 2.61).  
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Table 4: Predictors of ART adherence in Tepi health center (n=341) 
 
Variable Adherent No. (%) Non-adherent   No. (%) COR(95%CI) AOR(95% CI) 
Age 
    
18-24 61(41.8) 85(58.2) 1.78(0.713, 4.457) 1.37(0.49, 3.79) 
25-34 50(45.0) 61(55.0) 1.11(0.591, 2.081) 0.83(0.41, 1.69) 
35-44 22(39.3) 34(60.7) 1.27(0.659, 2.436) 1.04(0.50, 2.16) 
44+ 15(53.6) 13(46.4) 1.00 1.00 
Disclosure status 
    
Yes 136(44.7) 168(55.3) 1.69(0.82, 3.48) 0.94(0.36, 2.46) 
No 12(32.4) 25(67.6) 1.00 1.00 
Family support 
    
Yes 28(32.9) 57(67.1) 1.80(1.07, 3.01) 1.92(0.96, 3.83) 
No 120(46.9) 136(53.1) 1.00 1.00 
Alcohol use 
    
Yes 11(20.0) 44(80.0) 1.00 1.00 
No 137(47.9) 149(52.1) 3.69(1.83, 7.41) 4.36(2.03, 9.35) 
“ART cure HIV” 
    
Yes 65(37.1) 110(82.9) 1.00 1.00 
No 83(50.0) 83(50.0) 1.69(1.10, 2.61) 1.95(1.21, 3.13) 
WHO stage 
    
Stage 1 1(50.0) 1(50.0) 1.00 1.00 
Stage 2 19(32.2) 40(67.8) 0.46(0.03, 8.01) 0.45(0.23, 8.71) 
Stage 3 122(45.4) 147(54.6) 0.83(0.51, 13.41) 0.98(0.05, 18.0) 
Stage 4 6(54.5) 5(45.5) 1.20(0.59, 24.47) 1.85(0.08, 45.0) 
Recent CD4 C.     
No Data 70(37.2) 118(62.8) 0.70(0.29, 1.65) 0.49(0.19, 1.32) 
>500 cells/mm3 20(58.8) 14(41.2) 1.69(0.59, 4.65) 1.76(0.49, 6.23) 
350- 500  " 18(51.4) 17(48.6) 1.25(0.44, 3.55) 0.85(0.26, 2.80) 
200- 350  " 29(48.3) 31(51.7) 1.11(0.43, 2.86) 0.78(0.27, 2.27) 
<200       " 11(45.8) 13(54.2) 1.00 1.00 
Duration on HAART 
    
3-12 mo. 46(50.5) 45(49.5) 1.00 1.00 
13-24mo. 34(44.2) 43(55.8) 0.77(0.42, 1.42) 0.90(0.45, 1.82) 
25-36mo. 28(41.2) 40(58.8) 0.69(0.36, 1.29) 0.53(0.25, 1.13) 
37-48mo. 23(38.3) 37(61.7) 0.61(0.31, 1.18) 0.58(0.26, 1.29) 
49mo. 17(37.8) 28(62.2) 0.59(0.29, 1.23) 0.29(0.11, 0.75) 
Regimen 
    
TDF+3TC+NVP 12(63.2) 7(36.8) 1.00 1.00 
TDF+3TC+EFV 25(41.0) 36(59.0) 0.41(0.14, 1.17) 0.44(0.14, 1.33) 
AZT+3TC+NVP 32(50.8) 31(49.2) 0.60(0.21, 1.73) 0.69(0.22, 2.19) 
AZT+3TC+EFV 12(41.4) 17(58.6) 0.41(0.13, 1.35) 0.45(0.12, 1.66) 
D4T+3TC+NVP 45(39.8) 68(60.2) 0.39(0.14, 1.11) 0.58(0.19, 1.77) 
D4T+3TC+EFV 22(39.3) 34(60.7) 0.38(0.13, 1.11) 0.45(0.14, 1.44) 
 
Multivariate Analysis Result of Combined (Dose, Time 
and Food) Adherence 
Variables which were associated with the dependent 
variable P<0.25 and others that had been significant in 
the previous other studies were included in the model. All 
variables which were significant in bivariate analysis were 
also significant in multivariate model except family 
support. Duration on HAART was significant predictor in 
multivariate model. Not using alcohol was likely to 
increase adherence by odds of 4.36 (AOR= 4.36, 95% CI 
=2.03, 9.35), not having belief of “ART cures from 
HIV/AIDS” was likely to increase adherence by odds of 2 
(AOR = 1.95, 95% CI = 1.21, 3.13) and long-duration on 
HAART (≥49 months) decrease the odds of adherence by 
70% (AOR=0.29, 95%CI=0.11, 0.75).  
 
DISCUSSION 
The adherence status of clients to ART was assessed 
using patient self-report in this study; due to its simplicity, 
relatively inexpensive, and easy to implement in the 
patient’s follow-up. It can also provide information about 
the reasons why a patient did or did not take the 
medication properly. This type of adherence 
measurement was used in many studies in Ethiopia 
independently without other supplementary methods 
(Tadios and Davey, 2006; Amberbir Woldemichael et al., 
2008). This method has been shown to overestimate 
adherence both in the HIV setting and non-HIV setting 
and non-consistent results were found when compared to 
more objective measures (Michel Lionel et al., 2001). Self-
reported non-adherence is suggestive of worse virologic 
control (Miller and Hays, 2000; Michel Lionel et al., 2001).  
 
The adherence rate in this study was also presented 
using a combined (dose, time and food). Some studies 
use only dose adherence as a measurement 13, 14. Best 
adherence measurement has to assess whether or not 
dose is skipped, maintaining the scheduled time and food 
or dietary instructions agreed with the health provider to 
get the overall adherence rate. Recent studies prefer to 
use the combined measurement (Amberbir Woldemichael 
et al., 2008; Tiyou Belachew et al., 2010).  
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In this study the dose and food adherence were higher 
than the time adherence; unlike a study by Amberbir, 
Woldemichael et al. (2008). The rate of dose adherence in 
the study area was 78.6%; which was lower than reported 
in Southwest Ethiopia (Deribe Hailekiros et al., 2008; 
Tiyou Belachew et al., 2010) and nearer to studies from 
Northwest Ethiopia (Tessema Biadglegne et al., 2010).  
 
The overall rate of self reported adherence in this 
study area based on the combined indicators of the three 
adherence rates; dose, time and food was 43.4%. There 
are few studies in Ethiopia used the three adherence 
errors (dose, time and food) to obtain the combined 
adherence rates (Amberbir Woldemichael et al., 2008; 
Markos Worku et al., 2008 and Tiyou Belachew et al., 
2010). The overall adherence rate found in this study was 
much lesser than studies conducted in several parts of 
Ethiopia, which ranges from 72.4 to 79.3 (Amberbir 
Woldemichael et al., 2008; Tiyou Belachew et al., 2010). 
This may be partly attributed lowest level of the health 
facility in which the service is rendered. Health center in 
Ethiopian health care system is operated by low level 
health professional.  
 
Alcohol non-users were 4 times more likely to adhere 
than alcohol users (AOR=4.36, 95% CI = 2.03, 9.35). 
Alcohol use was significant predictor of non- adherence in 
many other studies. A prospective study conducted in 
USA revealed dose adherence rate for alcohol drinkers 
and non-drinkers were 66% and 74% respectively and 
adherence decreased by 8% among drinkers (Gardner 
Hullsiek et al., 2010). Alcohol use was a negative 
predictor of adherence in study conducted in south-west 
Ethiopia (Tessema Biadglegne et al., 2010).  Alcohol use 
negative association with adherence is mostly referred to 
impaired judgment and forgetfulness.  
 
Unlike to this finding, alcohol and substance use were 
not a significant negative predictor for adherence in cross 
sectional studies in Ethiopia (Amberbir Woldemichael et 
al., 2008; Markos Worku et al., 2008; Tiyou Belachew et 
al., 2010). This inconsistent finding may be partly 
attributed to missing the target groups (alcohol users) 
among study subjects. 
 
Believing “ART cures HIV/AIDS” decreases the odds 
of adherence 2 (AOR=1.95, 95% CI, 1.21, 3.13). The 
false belief may encourage the patients cease taking 
medication after improved quality of life. A study 
conducted in a general population in Kisumu, Kenya a 
belief of “ART cures HIV/AIDS” were associated with an 
increased HIV sero-prevalence (Talam Gatongi et al., 
2009). However we have not found studies used this 
variable to show its association with adherence in ART 
users. 
 
Duration on HAART is another significant predictor 
observed in this study, duration greater than or equal to 
49 months on treatment reduce the adherence by the 
odds of 70% (OR=0.29, 95% CI=0.11, 0.75). As duration 
on treatment prolongs quality of life improve, clients’ 
attention will be diverted to their daily routines than dosing 
their medication. Many studies reveal interest or 
motivation to adhere to medication will decrease when 
they have no symptom (Mathes Pieper et al., 2013; 
Nelsen Gupta et al., 2013; Rai Mahapatra et al., 2013). A 
study conducted in south-west Ethiopia, clients on WHO 
stage I are less likely to adhere to their treatment than 
advanced stages (COR=0.26, 95% CI= 0.07, 0.960) 
(Tiyou Belachew et al., 2010). Having good quality of life 
is therefore associated with impaired adherence because 
of the false perception of complete cure.  TB co-infection 
and its treatment have negative impact on adherence to 
antiretroviral therapy (Eyasu Mengistu et al., 2012). How 
such condition was not considered in this study.  
 
Social support may enhance adherence through 
encouragement, reassurance, reinforcement, systematic 
cues, bolstering of competence, and motivation, or by 
masking the effect of stress, anxiety, and depression 
(Tadios and Davey, 2006; Eyasu Mengistu et al., 2012). 
Family support was associated with adherence in the 
bivariate model of this study (COR=1.80, 95% CI = 1.07, 
3.01). However there was no significant association with 
adherence in the multivariate model. This might be due to 
the effect of confounders and smaller sample size. Other 
studies conducted in Ethiopia witnessed clients with family 
support were more likely to adhere than those who didn’t 
get family support (Amberbir Woldemichael et al., 2008; 
Tiyou Belachew et al., 2010).  
 
CONCLUSIONS  
Overall adherence rate in this study is lower than 
many other studies conducted in Ethiopia. Alcohol use, a 
longer duration on treatment and false belief “ART cures 
HIV” were negative predictors of adherence while social 
support was positive predictor in this study. Proper and 
uninterrupted counseling during initiation of therapy and 
follow-up visits are highly needed. Interventions should 
target on reduction of alcohol use and on imparting 
appropriate knowledge of ART that will address false 
beliefs of “ART cures HIV”.  
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